Health X Platform Ltd — Q1 FY27 earnings call
Summary generated by AI from the official transcript Health X Platform Ltd filed with BSE on 17 Aug 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries
The short read
Health X Platform reported Q1 FY27 revenue from operations growing over 58% year-on-year to Rs 440 crores, with RetailerShakti up 48% and SastaSundar up 44% year-on-year. Gross margin improved to 7.8% from 7.3% in Q4 FY26, EBITDA loss narrowed to Rs 15 crores from Rs 20 crores sequentially, and the company reported a PAT of Rs 2 crores compared to a loss of Rs 13 crores in Q4 FY26. Management discussed geographic expansion into Odisha, Bihar, Jharkhand and Chhattisgarh, the ramp-up of the JITO private label business, and plans to launch an AI-enabled RetailAir product in the current quarter.
Numbers mentioned
Revenue from operations: INR440 crores (Q1 FY27)
p. 5
“with revenue from operations growing more than 58% at year-on-year level to INR440 crores and registering a growth of over 16% on quarter-on-quarter basis from INR378 crores”
Lokesh Agarwal, page 5 of the filed PDF · View the filing
Gross profit: INR34 crores (Q1 FY27)
p. 5
“Gross profit increased by 64% year-on-year to INR34 crores and 24% quarter-on-quarter, while gross margin improved to 7.8% from 7.3% in quarter four of FY26.”
Lokesh Agarwal, page 5 of the filed PDF · View the filing
EBITDA loss: INR15 crores (Q1 FY27)
p. 5
“Operating profitability also improved sequentially, with EBITDA loss narrowing to INR15 crores from INR20 crores in Q4 FY26 and EBITDA margin improving to negative 3.4% from negative 5.5%.”
Lokesh Agarwal, page 5 of the filed PDF · View the filing
PAT: INR2 crores (Q1 FY27)
p. 5
“At PAT level, the company reported a profit of INR2 crores in Q1 FY27 marking a significant improvement from negative INR13 crores loss in Q4 FY26, although profitability remained below INR26 crores PAT reported in Q1 FY26.”
Lokesh Agarwal, page 5 of the filed PDF · View the filing
RetailerShakti growth: 48% Y-o-Y (Q1 FY27)
p. 3
“RetailerShakti grew 48% Y-o-Y, continuing to remain our principal growth engine.”
B.L. Mittal, page 3 of the filed PDF · View the filing
SastaSundar growth: 44% Y-o-Y (Q1 FY27)
p. 3
“While SastaSundar grew 44% Y-o-Y, reflecting a strong B2C business.”
B.L. Mittal, page 3 of the filed PDF · View the filing
EBITDA: INR14.9 crores (Q1 FY27)
p. 4
“EBITDA stood at INR14.9 crores during the quarter.”
B.L. Mittal, page 4 of the filed PDF · View the filing
Working capital cycle: approximately 28 days, roughly 8% of revenue
p. 5
“Our working capital cycle is approximately 28 days, equivalent to roughly 8% of revenue.”
B.L. Mittal, page 5 of the filed PDF · View the filing
JITO revenue: INR79 lakhs (Q1 FY27)
p. 7
“And this quarter we sold around 79 lakhs.”
B.L. Mittal, page 7 of the filed PDF · View the filing
July monthly revenue: INR150 crores plus (July 2026)
p. 6
“July, we ended with INR150 crores plus revenue.”
B.L. Mittal, page 6 of the filed PDF · View the filing
RetailerShakti gross margin: 7.8% (Q1 FY27)
p. 6
“So in Q1 FY27 at RetailerShakti, we are maintaining a gross margin of around 7.8% and EBITDA number we are closer to break even and expect to make positive EBITDA in Q3 this financial year end.”
Lokesh Agarwal, page 6 of the filed PDF · View the filing
Retail pharmacies served: approximately 75,000
p. 3
“We currently serve approximately 75,000 retail pharmacies with more than 50,000 SKUs sourced from over 1,000 vendors, supported by more than 350 health buddies and 3,500 employees.”
B.L. Mittal, page 3 of the filed PDF · View the filing
Active pharmacies (last 30 days): 40,000
p. 19
“But if you say last 30 days, pure super active, then 40,000 pharmacies are active in last 30 days.”
B.L. Mittal, page 19 of the filed PDF · View the filing
West Bengal market share: 3-4%
p. 19
“Current market share in Kolkata and West Bengal should be around 3%, 4%.”
B.L. Mittal, page 19 of the filed PDF · View the filing
What management said it would do
A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.
RetailerShakti EBITDA — positive EBITDA · Q3 FY27
stated firmly by Lokesh Agarwal
p. 6
“So in Q1 FY27 at RetailerShakti, we are maintaining a gross margin of around 7.8% and EBITDA number we are closer to break even and expect to make positive EBITDA in Q3 this financial year end.”
Lokesh Agarwal, page 6 of the filed PDF · View the filing
Gross margin — 8% plus · FY27
stated firmly by B.L. Mittal
p. 9
“Entire year we will be maintaining 8% plus gross margin.”
B.L. Mittal, page 9 of the filed PDF · View the filing
Gross margin — around 12%
stated as an aspiration by B.L. Mittal
p. 10
“As I said that it will run to 12%, from 8% to 12% if you look the industry.”
B.L. Mittal, page 10 of the filed PDF · View the filing
RetailAir product launch — this quarter
stated firmly by B.L. Mittal
p. 5
“We are continuously working to launch our AI-monitored RetailAir product for our retailers, and we are scheduled to launch in this quarter.”
B.L. Mittal, page 5 of the filed PDF · View the filing
Healthbuddy to JITO conversion — around 50% of Healthbuddies · next 3 months
stated firmly by B.L. Mittal
p. 17
“So around 50% of the Healthbuddy will be converted into JITO in next 3 months time.”
B.L. Mittal, page 17 of the filed PDF · View the filing
West Bengal market share — double, around 7% · next two, three years
stated as an aspiration by B.L. Mittal
p. 19
“In next two, three years we want to make it double from here, so say 7%.”
B.L. Mittal, page 19 of the filed PDF · View the filing
Existing infrastructure revenue capacity — INR2500 crores to INR3000 crores · 2028
stated firmly by B.L. Mittal
p. 17
“So INR2500 crores to INR3000 crores it means next year 2028 we don't have any issue for the existing infrastructure.”
B.L. Mittal, page 17 of the filed PDF · View the filing
Guwahati warehouse construction — 75,000 sq. ft. · next 6 months
stated firmly by B.L. Mittal
p. 16
“Guwahati, we have expanded existing capacity by taking new warehouse on rent, and 75,000 sq. ft. this we are starting the construction in next 6 months’ time.”
B.L. Mittal, page 16 of the filed PDF · View the filing
Patna and Lucknow warehouse start — next 2-3 months
stated firmly by B.L. Mittal
p. 16
“Patna and Lucknow we will start in next 2 months, 3 months.”
B.L. Mittal, page 16 of the filed PDF · View the filing
SEBI merger/demerger approval
stated conditionally by B.L. Mittal
p. 18
“We have started taking questions from stock exchange and replying them.”
B.L. Mittal, page 18 of the filed PDF · View the filing
Q&A highlights
Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.
Gross margin was around 7.8% with EBITDA close to break-even, expected to turn positive by Q3 FY27.
Answered by Lokesh Agarwal
Asked by Sanchita Sood: What is the gross margin and EBITDA margin for RetailerShakti in Q1 FY27?
p. 6
“So in Q1 FY27 at RetailerShakti, we are maintaining a gross margin of around 7.8% and EBITDA number we are closer to break even and expect to make positive EBITDA in Q3 this financial year end.”
Lokesh Agarwal, page 6 of the filed PDF · View the filing
Management expects consolidated gross margin to reach around 12% as JITO scales and wallet share increases, and said the focus is cash flow rather than EBITDA.
Answered by B.L. Mittal
Asked by Abhishek Singhal: What is the gross margin potential of the business, including the impact of JITO?
p. 7
“So the gross margin if we see the industry level that taken together of both B2B and B2C, we expect to pan out of around 12% going forward.”
B.L. Mittal, page 7 of the filed PDF · View the filing
Management said EBITDA is not the priority for SastaSundar for the next two-three years, as spend is going into technology and revenue building rather than depreciation.
Answered by B.L. Mittal
Asked by Disha: What is the gross margin and EBITDA margin for the Health Buddy/SastaSundar platform?
p. 9
“We are not an EBITDA positive company for the next two, three years and we neither look the EBITDA from perspective.”
B.L. Mittal, page 9 of the filed PDF · View the filing
Management estimated roughly 25-30% towards marketing/branding and 40-45% towards technology costs.
Answered by Lokesh Agarwal
Asked by Amit Mehendale: Can you provide a split of the SastaSundar burn between technology, branding and customer acquisition?
p. 15
“So, breakup of this burning is somewhere around 25% to 30% is towards marketing and advertisement, while the 40% to 45% goes towards tech related cost.”
Lokesh Agarwal, page 15 of the filed PDF · View the filing
Management said RetailerShakti remains on track for break-even this year, but SastaSundar/B2C break-even was never guided for the current year.
Answered by B.L. Mittal
Asked by Ramesh: Has the EBITDA break-even timeline been pushed out from earlier guidance?
p. 15
“The RetailerShakti we earlier said that we will achieve the break even this year. We are near to break even and because the burning is coming by virtue of our B2C business, we have never said that taking together B2C we will achieve the break even in the current year.”
B.L. Mittal, page 15 of the filed PDF · View the filing
Existing infrastructure can support up to roughly 100% growth from current levels before major new capacity is needed.
Answered by B.L. Mittal
Asked by Abhishek Singhal: What top line can current warehouse infrastructure sustain and how is automation being scaled?
p. 17
“So our existing warehouse infrastructure or fulfilment center infrastructure are ready to take up around 100% growth from the current level.”
B.L. Mittal, page 17 of the filed PDF · View the filing
Management said there were no licensing issues and the merger/demerger process was progressing with stock exchange queries being addressed.
Answered by B.L. Mittal
Asked by Preet Shah: Are there any regulatory or permitting issues for upcoming warehouses, and is the SEBI merger/demerger scheme on track?
p. 18
“Yes, yes, we are absolutely on track. We have started taking questions from stock exchange and replying them.”
B.L. Mittal, page 18 of the filed PDF · View the filing
Average wallet share is around 2%, with a target to double it once the RetailAir SaaS product launches.
Answered by B.L. Mittal
Asked by Neelam Punjabi: What is the current wallet share per pharmacy and the target for increasing it?
p. 19
“So somewhere around 2% would be the average wallet share.”
B.L. Mittal, page 19 of the filed PDF · View the filing
Risks flagged
SastaSundar/B2C business requires significant ongoing investment before reaching EBITDA profitability
p. 9
“We are not an EBITDA positive company for the next two, three years and we neither look the EBITDA from perspective.”
B.L. Mittal, page 9 of the filed PDF · View the filing
Depreciation and interest costs erode gross margin in traditional distribution models
p. 7
“If you see the beautiful companies, they kill the gross margin earned in their depreciation and the depreciation is the real cost.”
B.L. Mittal, page 7 of the filed PDF · View the filing
Segment-wise P&L disclosure is not currently possible due to integrated cost structure
p. 15
“We are thinking about that, but right now what is happening, the 2/3 of the activities like procurement, fulfilment, and tech are so integrated that carve out is not becoming possible.”
B.L. Mittal, page 15 of the filed PDF · View the filing
Massive new infrastructure investment will be required as growth scales beyond current warehouse capacity
p. 18
“Then we will need a massive amount of infrastructure development for building a seamless infrastructure into a large company.”
B.L. Mittal, page 18 of the filed PDF · View the filing
Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.